108 related articles for article (PubMed ID: 15530255)
1. Evidence-based approaches to overcoming barriers to clinical trial accrual.
Edelman MJ
Cancer J; 2004; 10(5):288-9. PubMed ID: 15530255
[No Abstract] [Full Text] [Related]
2. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California.
Martel CL; Li Y; Beckett L; Chew H; Christensen S; Davies A; Lam KS; Lau DH; Meyers FJ; O'donnell RT; Richman C; Scudder S; Tanaka M; Tuscano J; Welborn J; Wun T; Gandara DR; Lara PN
Cancer J; 2004; 10(5):294-300. PubMed ID: 15530258
[TBL] [Abstract][Full Text] [Related]
3. Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.
Ellis SD; Carpenter WR; Minasian LM; Weiner BJ
Contemp Clin Trials; 2012 Sep; 33(5):933-41. PubMed ID: 22683991
[TBL] [Abstract][Full Text] [Related]
4. Mandatory health insurance coverage for cancer clinical trials.
Murphy LC
McGeorge Law Rev; 2001-2002; 33():314-22. PubMed ID: 15871150
[No Abstract] [Full Text] [Related]
5. Support the "Access to Cancer Clinical Trials Act" to ensure coverage of routine patient-care costs.
Halpern IM; Waters B
ONS News; 2002 Sep; 17(9):6. PubMed ID: 12244867
[No Abstract] [Full Text] [Related]
6. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital.
Joseph G; Dohan D
Contemp Clin Trials; 2009 Nov; 30(6):552-9. PubMed ID: 19580887
[TBL] [Abstract][Full Text] [Related]
7. Arizona's cancer clinical trials law: flawed process, flawed product.
Olson-Garewal JK; Hessler K
Hastings Cent Rep; 2001; 31(3):22-4. PubMed ID: 11478120
[No Abstract] [Full Text] [Related]
8. Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign.
Umutyan A; Chiechi C; Beckett LA; Paterniti DA; Turrell C; Gandara DR; Davis SW; Wun T; Chen MS; Lara PN
Cancer; 2008 Jan; 112(1):212-9. PubMed ID: 18008353
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
[TBL] [Abstract][Full Text] [Related]
10. Strengthening accrual to cancer clinical trials.
Trimble EL; Denicoff AM; Abrams JS
Gynecol Oncol; 2010 Mar; 116(3):291-2. PubMed ID: 20152512
[No Abstract] [Full Text] [Related]
11. Insurance Denial of Coverage for Patients Enrolled in Cancer Clinical Trials Is Still a Problem in the Affordable Care Act Era.
Jain N; Steensma D; Stewart DJ; Kantarjian H
J Oncol Pract; 2016 Apr; 12(4):283-5. PubMed ID: 26907450
[No Abstract] [Full Text] [Related]
12. Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate.
Mackay CB; Antonelli KR; Bruinooge SS; Saint Onge JM; Ellis SD
Cancer; 2017 Aug; 123(15):2893-2900. PubMed ID: 28334438
[TBL] [Abstract][Full Text] [Related]
13. Stat bite: State mandates for insurance coverage of clinical trials.
J Natl Cancer Inst; 2003 Sep; 95(17):1269. PubMed ID: 12953077
[No Abstract] [Full Text] [Related]
14. More states mandate coverage of clinical trial costs, but does it make a difference?
McBride G
J Natl Cancer Inst; 2003 Sep; 95(17):1268-9. PubMed ID: 12953076
[No Abstract] [Full Text] [Related]
15. Surveys identify barriers to participation in clinical trials.
Finn R
J Natl Cancer Inst; 2000 Oct; 92(19):1556-8. PubMed ID: 11018085
[No Abstract] [Full Text] [Related]
16. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC
J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272
[TBL] [Abstract][Full Text] [Related]
17. Social media in clinical trials.
Thompson MA
Am Soc Clin Oncol Educ Book; 2014; ():e101-5. PubMed ID: 24857086
[TBL] [Abstract][Full Text] [Related]
18. Medicare's revised clinical trial policy and clinical trial-related provisions of FDAAA: what is a sponsor to do?
Dobbins K; Scanlan K
Food Drug Law J; 2007; 62(4):695-708. PubMed ID: 18557226
[No Abstract] [Full Text] [Related]
19. Barriers to clinical trial recruitment in head and neck cancer.
Haddad RI; Chan AT; Vermorken JB
Oral Oncol; 2015 Mar; 51(3):203-11. PubMed ID: 25593017
[TBL] [Abstract][Full Text] [Related]
20. Use of crowdsourcing for cancer clinical trial development.
Leiter A; Sablinski T; Diefenbach M; Foster M; Greenberg A; Holland J; Oh WK; Galsky MD
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
